Life Expectancy for HIV+ Patients Up Since Introduction of ART

This article originally appeared here.
Share this content:
Life Expectancy for HIV+ Patients Up Since Introduction of ART
Life Expectancy for HIV+ Patients Up Since Introduction of ART

THURSDAY, May 11, 2017 (HealthDay News) -- Young adults with HIV who get treatment are living longer in North America and Europe, according to a study published online May 10 in The Lancet HIV.

In fact, a 20-year-old with HIV who began antiretroviral treatment in 2008 or later and had a low viral load after a year of treatment has a life expectancy that's close to that of the general population -- around 78 years old, the study authors found. But life expectancy for people with HIV mostly remains lower than that of the general population.

"Our research illustrates a success story of how improved HIV treatments coupled with screening, prevention, and treatment of health problems associated with HIV infection can extend the life span of people diagnosed with HIV," lead author Adam Trickey, from the University of Bristol in the United Kingdom, said in a journal news release. "However, further efforts are needed if life expectancy is to match that of the general population."

Trickey said the focus needs to be on encouraging patients to take their drugs consistently. It's also important for people to be diagnosed earlier, and to diagnose and treat other conditions that can occur with HIV, such as hepatitis C. He said that treatment for addiction also needs to be available.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Zika Does Not Appear to Last in Semen As Long As Thought

Zika Does Not Appear to Last in Semen ...

More research is needed to better inform public health recommendations

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke Risk

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke ...

I-131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke

Higher Odds of Infection With Reduced Kidney Function

Higher Odds of Infection With Reduced Kidney Function

Study finds excess community-acquired infections incidence in individuals with mild to severe CKD

is free, fast, and customized just for you!

Already a member?

Sign In Now »